Search

everythinglearnresearchcommunity

for

Search:↓

Antituberculosis drugs can cause severe skin reactions, requiring careful diagnosis and treatment.

JAK inhibitors show promise for treating various skin diseases.

CG2001 is safe and well-tolerated for treating hair loss, with fewer side effects than oral finasteride.

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

Anti-angiogenic therapy can help treat cancer but may cause resistance and side effects, so alternative methods are being explored.

Extracellular vesicles show promise for medical use but face challenges in standardization and safety.

Beau's lines on nails may indicate severe COVID-19 or vaccination response.

Nanomedicine-based immunotherapy shows promise in improving tissue repair and regeneration.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Mesotherapy is a skin injection therapy used for pain and local conditions, with scientific support but needing more clinical trials.

Photobiomodulation is safe for skin rejuvenation, even for those with a cancer history.

Gynostemma pentaphyllum extract improves hair elasticity, density, and thickness safely.

ThriveCo Anti-Dandruff Pre-Shampoo Treatment effectively reduces dandruff and improves scalp health without side effects.

Micronized-gingival connective tissues are safe and may help regenerate soft tissue around dental implants.

The convention highlighted the importance of comprehensive patient care and early diagnosis in dermatology.

Nutraceutical insulin-sensitizing agents may help treat skin conditions like psoriasis and acne.

Botulinum toxins are safe for various medical and cosmetic uses, but more research is needed for long-term safety and effectiveness in hair growth treatments.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Hair follicle bulge cells don't help skin regrow after glucocorticoid damage; interfollicular epidermis cells do.

Some patients treated with peginterferon and ribavirin for chronic hepatitis C had mild to moderate skin reactions, but treatment did not need to be stopped.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.

Skin problems in older people can indicate hormonal diseases, nutritional deficiencies, or conditions like diabetes, menopause, and HIV.

Albendazole can cause hair loss, and piroxicam can cause fixed drug eruption.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.